Prikind's R&D organization focuses on formulation excellence, stability science, cost-effective processes, and patient-centric packaging. Our research drives product differentiation while ensuring regulatory compliance and manufacturability at scale.
We use analytical techniques and data-driven experiments to accelerate development:
Our R&D labs are equipped for both formulation and analytical projects, supporting quick scale-up to manufacturing:
We partner with academic institutions, CROs, and third-party labs to accelerate validation and regulatory readiness:
Selected projects that showcase our focus on patient needs and manufacturability.
Taste-masked, low-sugar syrup with child-safe dosing system; stability validated for 24 months at ambient conditions.
Controlled-release matrix tablet to improve adherence and reduce dosing frequency.
Improved omega and vitamin stability via microencapsulation for extended shelf-life.
Process tweaks that reduced solvent and raw material waste by ~8% in pilot runs.
We document key learnings and file IP when appropriate.
Whether you need formulation support, private-label R&D, or co-development — our team can help. Share your brief and we will respond with feasibility and timelines.